Stockscreener 앱 받기
109.00
1.67%
-1.85
시간 외 거래:
109.00
전일 마감가:
$110.85
열려 있는:
$110.77
하루 거래량:
237.31K
Relative Volume:
1.23
시가총액:
$2.48B
수익:
$249.60M
순이익/손실:
$57.73M
주가수익비율:
43.36
EPS:
2.5139
순현금흐름:
$74.47M
1주 성능:
+2.31%
1개월 성능:
+18.66%
6개월 성능:
+18.16%
1년 성능:
+28.51%
1일 변동 폭
$107.23
$111.75
1주일 범위
$106.57
$113.34
52주 변동 폭
$71.42
$115.33
Lemaitre Vascular Inc Stock (LMAT) Company Profile
명칭
Lemaitre Vascular Inc
전화
781-221-2266
주소
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT vs ISRG, BDX, ALC, MDLN, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
109.00 | 2.52B | 249.60M | 57.73M | 74.47M | 2.5139 |
|
ISRG
Intuitive Surgical Inc
|
479.93 | 169.66B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
156.53 | 44.97B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
75.01 | 36.92B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
43.59 | 34.30B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
227.41 | 33.20B | 5.40B | 1.49B | 1.78B | 10.12 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-06 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2025-02-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2025-02-28 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2025-02-13 | 개시 | Wells Fargo | Equal Weight |
| 2024-10-15 | 개시 | Cantor Fitzgerald | Neutral |
| 2024-08-02 | 재개 | Lake Street | Buy |
| 2024-05-31 | 재개 | ROTH MKM | Buy |
| 2024-04-26 | 업그레이드 | Stifel | Hold → Buy |
| 2024-02-06 | 재개 | KeyBanc Capital Markets | Sector Weight |
| 2023-10-23 | 개시 | JMP Securities | Mkt Outperform |
| 2023-09-06 | 개시 | Oppenheimer | Outperform |
| 2023-08-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-05-03 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2022-10-28 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2021-09-16 | 개시 | Jefferies | Buy |
| 2021-02-12 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2020-03-16 | 업그레이드 | Sidoti | Neutral → Buy |
| 2019-10-24 | 다운그레이드 | First Analysis Sec | Strong Buy → Outperform |
| 2019-10-24 | 업그레이드 | Lake Street | Hold → Buy |
| 2019-10-14 | 업그레이드 | First Analysis Sec | Outperform → Strong Buy |
| 2019-07-25 | 재확인 | Barrington Research | Outperform |
| 2019-07-25 | 업그레이드 | First Analysis Sec | Neutral → Outperform |
| 2018-10-08 | 업그레이드 | Barrington Research | Mkt Perform → Outperform |
| 2018-10-08 | 업그레이드 | ROTH Capital | Neutral → Buy |
| 2018-06-08 | 재개 | ROTH Capital | Buy |
| 2018-04-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-04-26 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2017-10-27 | 다운그레이드 | First Analysis Sec | Overweight → Equal-Weight |
| 2017-10-27 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2017-07-10 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2017-07-10 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2017-03-21 | 개시 | First Analysis Sec | Overweight |
| 2017-02-22 | 다운그레이드 | Barrington Research | Outperform → Mkt Perform |
| 2016-09-22 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2016-07-28 | 재확인 | Barrington Research | Outperform |
| 2016-02-25 | 재확인 | Barrington Research | Outperform |
모두보기
Lemaitre Vascular Inc 주식(LMAT)의 최신 뉴스
LeMaitre Vascular declares $0.20 dividend - MSN
LeMaitre Vascular, Inc. (LMAT): A bull case theory - MSN
LeMaitre Vascular (LMAT)'s technical outlook is bright after key golden cross - MSN
Assessing LeMaitre Vascular (LMAT) Valuation After Strong Recent Share Price Momentum - simplywall.st
LeMaitre Vascular Inc (NASDAQ:LMAT) Passes Key Quality Investing Screens - ChartMill
Insider Sell: David Roberts Sells Shares of LeMaitre Vascular In - GuruFocus
LeMaitre Vascular (LMAT) SVP exercises options, sells 2,625 shares - Stock Titan
LeMaitre Vascular (LMAT) president sells 3,311.68 shares in open market trade - Stock Titan
Kennedy Capital Management LLC Has $18.89 Million Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
3 Healthcare Stocks to Avoid in 2026: Analysis of UnderperformersNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
LeMaitre (NASDAQ: LMAT) CFO exercises dividend rights and uses shares for taxes - Stock Titan
LMAT (NASDAQ) Form 144: Trent Kamke plans sale of 2,625 shares via option exercise - Stock Titan
Director sale: 8,464 shares by David B. Roberts (LMAT) - Stock Titan
LeMaitre Vascular, Inc.: - marketscreener.com
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Announces Quarterly Dividend of $0.25 - MarketBeat
First Trust Advisors LP Grows Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Stronger 2025 Results, Higher Dividend and Buyback Might Change The Case For Investing In LeMaitre Vascular (LMAT) - simplywall.st
Why Is LeMaitre Vascular, Inc. (LMAT) Stock Down Today? - Meyka
Avoiding Lag: Real-Time Signals in (LMAT) Movement - Stock Traders Daily
LeMaitre Vascular Stock Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo
LeMaitre Vascular Experiences Revision in Its Stock Evaluation Amid Competitive Market Dynamics - Markets Mojo
Is LeMaitre Vascular Inc. stock a safe haven assetTrade Exit Summary & Verified Momentum Watchlists - Naître et grandir
Is LeMaitre Vascular Inc stock showing strong momentumMarket Trend Review & Low Risk Entry Point Guides - baoquankhu1.vn
LeMaitre Vascular Hits Day High with 24.41% Surge in Stock Price - Markets Mojo
LeMaitre Vascular, Inc. $LMAT Shares Sold by JPMorgan Chase & Co. - MarketBeat
LeMaitre Vascular Stock: Why Wall Street Sees $109 Mean Target - TIKR.com
Lemaitre Vascular Stock Quote, Share Price, News and Analysis - Longbridge
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of "Hold" from Analysts - MarketBeat
LeMaitre Vascular Experiences Revision in Stock Evaluation Amid Strong Performance Metrics - Markets Mojo
LeMaitre Vascular Hits New 52-Week High at $115.33, Up 46.41% - Markets Mojo
LMAT SEC FilingsLemaitre Vasculr 10-K, 10-Q, 8-K Forms - Stock Titan
LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Strong Buy Ratings Amid Steady Revenue Growth - DirectorsTalk Interviews
Lemaitre Vascular SVP Kamke sells $115k in LMAT stock By Investing.com - Investing.com Australia
LeMaitre (NASDAQ: LMAT) director gains PSU-based stock and dividend rights - Stock Titan
LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $6,029,813.30 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Director Sells $903,955.20 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) CEO Sells $16,014,000.00 in Stock - MarketBeat
LeMaitre Vascular (NASDAQ:LMAT) Insider Sells $115,142.76 in Stock - MarketBeat
Lemaitre Vascular SVP Kamke sells $115k in LMAT stock - Investing.com
LeMaitre Vascular (LMAT) president reports sale of 8,464 shares - Stock Titan
LeMaitre Vascular (LMAT) director gains stock through PSU vesting and dividend rights - Stock Titan
LMAT (LMAT) CEO LeMaitre reports 205,930-share sale, PSU vesting and gift - Stock Titan
George W. LeMaitre sells 150,000 shares (LMAT) in Form 144 - Stock Titan
LeMaitre Vascular (LMAT)'s Technical Outlook is Bright After Key Golden Cross - sharewise.com
LeMaitre Vascular (LMAT) Is Up 16.4% After Dividend Hike And Buyback Plan – Has The Bull Case Changed? - Yahoo Finance
LeMaitre Vascular (LMAT) Shows Promising Technical Prospects Following Significant Golden Cross - Bitget
How The LeMaitre Vascular (LMAT) Investment Story Is Evolving With New Targets And Guidance - Yahoo Finance
LeMaitre Vascular Signals Confident Growth in Earnings Call - The Globe and Mail
LeMaitre Vascular Links Strong 2025 Results To Higher Shareholder Returns - simplywall.st
LeMaitre Vascular, Inc. (LMAT): A Bull Case Theory - Yahoo Finance
LeMaitre to Participate at Upcoming Investor Conferences in March - The Manila Times
Lemaitre Vascular Inc (LMAT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.06%
0.65%
자본화:
|
볼륨(24시간):